2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation. Translation of the document prepared by the Czech Society of Cardiology

被引：1

作者：

Taborsky, Milos ^{[1
,2
]}

Kautzner, Josef ^{[3
]}

Fedorco, Marian ^{[1
,2
]}

Curila, Karol ^{[4
,5
]}

Wunschova, Hanka

Pyszko, Jan ^{[1
,2
]}

Novak, Miroslav ^{[6
,7
]}

Kozak, Milan ^{[8
,9
]}

Valek, Martin ^{[10
,11
]}

Polasek, Rostislav ^{[12
]}

Keprt, Patrik

Kubickova, Milena ^{[13
,14
,15
]}

Plasek, Jiri ^{[16
,17
]}

Gloger, Vit ^{[18
]}

Bulava, Alan ^{[19
,20
]}

Vancura, Vlastimil ^{[21
,22
]}

Skala, Tomas ^{[1
,2
]}

Parizek, Petr ^{[23
,24
]}

Danek, Josef ^{[25
,26
]}

机构：

[1] Univ Palackeho Olomouci, Lekarska Fak, Interni Klin Kardiol 1, IP Pavlova 6, Olomouc 77900, Czech Republic

[2] Fak Nemocnice Olomouc, IP Pavlova 6, Olomouc 77900, Czech Republic

[3] Inst Klin Expt Med, Klin Kardiol, Prague, Czech Republic

[4] Univ Karlovy, Lekarska Fak 3, Kardiol Klin, Prague, Czech Republic

[5] Fak Nemocnice Kralovske Vinohrady, Prague, Czech Republic

[6] Masarykovy Univ, Lekarska Fak, Interni Kardioangiol Klin 1, Brno, Czech Republic

[7] Fak Nemocnice Sv Anny Brne, Brno, Czech Republic

[8] Masarykovy Univ, Lekarska Fak, Interni Kardiol Klin, Brno, Czech Republic

[9] Fak Nemocnice Brno, Brno, Czech Republic

[10] Univ Karlovy, Lekarska Fak 1, Interni Klin Kardiol & Angiol, Prague, Czech Republic

[11] Vseobecna Fak Nemocnice Praze, Prague, Czech Republic

[12] Krajska Nemocnice Liberec As, Kardiovask Ctr, Liberec, Czech Republic

[13] Univ JE Purkyne Usti Nad Labem, Fak Zdravotnickych, Kardiol Klin, Usti Nad Labem, Czech Republic

[14] Krajska Zdravotni As, Usti Nad Labem, Czech Republic

[15] Masarykova Nemocnice Usti Nad Labem, Oz, Usti Nad Labem, Czech Republic

[16] Ostravske Univ, Lekarska Fak, Interni Kardiol Klin, Ostrava, Czech Republic

[17] Fak Nemocnice Ostrava, Ostrava, Czech Republic

[18] Krajska Nemocnice Tomase Bati Zline, Kardiol Oddeleni, Zlin, Czech Republic

[19] Nemocnice Ceske Budejovice As, Kardiol Oddeleni, Ceske Budejovice, Czech Republic

[20] Jihoceske Univ Ceskych Budejovicich, Zdravotne Socialni Fak, Ceske Budejovice, Czech Republic

[21] Univ Karlova, Lekarska Fak Plzen, Kardiol Klin, Plzen, Czech Republic

[22] Fak Nemocnice Plzen, Plzen, Czech Republic

[23] Univ Karlovy, Lekarska Fak, Interni Kardioangiol Klin 1, L, Hradec Kralove, Czech Republic

[24] Fak Nemocnice Hradec Kralove, Hradec Kralove, Czech Republic

[25] Univ Karlovy, Lekarska Fak 1, Interni Klin, Kardiol Oddeleni, Prague, Czech Republic

[26] Ustredni Vojenska Nemocnice, Prague, Czech Republic

来源：

COR ET VASA | 2023年 / 65卷

关键词：

apixaban; dabigatran; DOACs; edoxaban; NOACs; rivaroxaban;

D O I：

10.33678/cor.2023.024

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：23 / 75

页数：53

共 50 条

[1] 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation
Steffel, Jan
Collins, Ronan
Antz, Matthias
Cornu, Pieter
Desteghe, Lien
Haeusler, Karl Georg
Oldgren, Jonas
Reinecke, Holger
Roldan-Schilling, Vanessa
Rowell, Nigel
Sinnaeve, Peter
Vanassche, Thomas
Potpara, Tatjana
Camm, A. John
Heidbuechel, Hein
Lip, Gregory Y. H.
Deneke, Thomas
Dagres, Nikolaos
Boriani, Giuseppe
Chao, Tze-Fan
Choi, Eue-Keun
Hills, Mellanie True
Santos, Itamar de Souza
Lane, Deirdre A.
Atar, Dan
Joung, Boyoung
Cole, Oana Maria
Field, Mark
EUROPACE, 2021, 23 (10): : 1612 - 1676
[2] RECOMMENDATIONS ON THE USE OF NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION (BASED ON 2018 EUROPEAN HEART RHYTHM ASSOCIATION PRACTICAL GUIDE)
Popova, L., V
Kondratieva, T. B.
Aksenova, M. B.
Khlevchuk, T., V
Kanevskaya, M. Z.
KARDIOLOGIYA, 2019, 59 (05) : 68 - 79
[3] Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Disease
Renda, Giulia
Ricci, Fabrizio
Giugliano, Robert P.
De Caterina, Raffaele
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1363 - 1371
[4] Cessation of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Middeldorp, Melissa E.
Gupta, Aashray
Elliott, Adrian
Kadhim, Kadhim
Thiyagarajah, Anand
Gallagher, Celine
Hendriks, Jeroen
Linz, Dominik
Emami, Mehrdad
Mahajan, Rajiv
Lau, Dennis
Sanders, Prashanthan
HEART, 2021, 107 (12) : 971 - 976
[5] Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation and Valvular Heart Disease
Moon, Inki
Lee, So-Ryoung
Choi, Eue-Keun
Lee, Euijae
Jung, Jin-Hyung
Han, Kyung-Do
Cha, Myung-Jin
Oh, Seil
Lip, Gregory Y. H.
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (10)
[6] The European Heart Rhythm Association Practical Guide on the Use of New Oral Anticoagulants in Patients with Non-valvular Atrial Fibrillation - A Brief Summary
Kirchhof, Paulus
ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW, 2013, 2 (02) : 115 - 119
[7] Effect of non-vitamin K antagonist oral anticoagulants versus warfarin in heart failure patients with atrial fibrillation
Chen, Faxiu
Zhou, Yunguo
Wan, Qin
Yu, Peng
Ma, Jianyong
Hu, Jian
HEART FAILURE REVIEWS, 2021, 26 (06) : 1391 - 1397
[8] Low-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Lee, Ki Hong
Park, Hyung Wook
KOREAN JOURNAL OF INTERNAL MEDICINE, 2023, 38 (05) : 583 - 594
[9] Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary
Heidbuchel, Hein
Verhamme, Peter
Alings, Marco
Antz, Matthias
Diener, Hans-Christoph
Hacke, Werner
Oldgren, Jonas
Sinnaeve, Peter
Camm, A. John
Kirchhof, Paulus
EUROPEAN HEART JOURNAL, 2017, 38 (27) : 2137 - 2149
[10] Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Thrombocytopenia
Janion-Sadowska, Agnieszka
Papuga-Szela, Elbieta
Lukaszuk, Robert
Chrapek, Magdalena
Undas, Anetta
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2018, 72 (03) : 153 - 160

← 1 2 3 4 5 →